Basics |
ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary is engaged in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals.
|
IPO Date: |
July 18, 2013 |
Sector: |
Healthcare |
Industry: |
Pharma |
Market Cap: |
$1.49B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.91 | 2.07%
|
Avg Daily Range (30 D): |
$1.16 | 1.77%
|
Avg Daily Range (90 D): |
$0.94 | 1.54%
|
Institutional Daily Volume |
Avg Daily Volume: |
.14M |
Avg Daily Volume (30 D): |
.27M |
Avg Daily Volume (90 D): |
.2M |
Trade Size |
Avg Trade Size (Sh.): |
71 |
Avg Trade Size (Sh.) (30 D): |
42 |
Avg Trade Size (Sh.) (90 D): |
41 |
Institutional Trades |
Total Inst.Trades: |
1,907 |
Avg Inst. Trade: |
$1.8M |
Avg Inst. Trade (30 D): |
$2.99M |
Avg Inst. Trade (90 D): |
$2.69M |
Avg Inst. Trade Volume: |
.03M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.08M |
Avg Closing Trade (30 D): |
$3.96M |
Avg Closing Trade (90 D): |
$3.44M |
Avg Closing Volume: |
36.95K |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-1.04
|
$-.55
|
$-1.04
|
Diluted EPS
|
$-1.04
|
$-.55
|
$-1.04
|
Revenue
|
$ 614.38M
|
$ 190.57M
|
$ 614.38M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -18.52M
|
$ -10.28M
|
$ -18.52M
|
Operating Income / Loss
|
$ .58M
|
$ -4.38M
|
$ .58M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -76.23M
|
$ -.12M
|
$ -76.23M
|
PE Ratio
|
|
|
|
Splits |
Jul 18, 2013:
6:1
|
Jun 04, 2012:
6:1
|
Jun 03, 2002:
10:1
|
|